CHINA PHARMA HOLDINGS, INC. Accrued Liabilities, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Accrued Liabilities, Current of $500.16 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accrued Liabilities, Current $500.16K.
- 2026-03-31: Accrued Liabilities, Current $311.34K.
- 2025-12-31: Accrued Liabilities, Current $350.64K.
- 2025-09-30: Accrued Liabilities, Current $170.43K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $500.16K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $311.34K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $350.64K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $170.43K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $191.29K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $195.26K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $247.16K 10-K · filed 2026-04-01 |
| 2024-09-30 | $82.61K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $208.83K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $298.83K 10-K · filed 2025-03-31 |
| 2023-09-30 | $119.67K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $120.56K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $113.75K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $404.81K 10-K · filed 2024-04-01 |
| 2022-09-30 | $126.52K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $110.39K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $138.22K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $298.45K 10-K · filed 2023-03-30 |
| 2021-09-30 | $227.42K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $332.39K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $201.84K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $177.36K 10-K · filed 2022-03-30 |
| 2020-09-30 | $160.53K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $180.72K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $245.74K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $189.88K 10-K · filed 2021-03-26 |
| 2019-09-30 | $140.75K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $105.49K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $117.24K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $310.80K 10-K · filed 2020-03-30 |
| 2018-09-30 | $182.69K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $195.05K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $334.40K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $276.37K 10-K · filed 2019-03-28 |
| 2017-09-30 | $321.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $129.52K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $90.23K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $139.83K 10-K · filed 2018-04-02 |
| 2016-09-30 | $91.70K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $39.93K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $113.63K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $143.41K 10-K · filed 2017-03-31 |
| 2015-09-30 | $221.86K 10-Q · filed 2015-12-28 |
| 2015-06-30 | $253.01K 10-Q · filed 2015-12-28 |
| 2015-03-31 | $260.80K 10-Q · filed 2015-12-28 |
| 2014-12-31 | $269.87K 10-K · filed 2016-03-30 |
| 2014-09-30 | $214.74K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $293.54K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $287.58K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $323.65K 10-K · filed 2015-12-28 |
| 2013-09-30 | $277.16K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $258.62K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $240.00K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $202.19K 10-K · filed 2014-03-20 |
| 2012-09-30 | $193.09K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $161.76K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $145.21K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $184.02K 10-K · filed 2013-03-14 |
| 2011-09-30 | $136.68K 10-Q/A · filed 2012-03-06 |
| 2011-06-30 | $82.13K 10-Q/A · filed 2011-09-06 |
| 2010-12-31 | $98.21K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |